Evidence map›Paper›PMID 36498925›Full record

ArticleInternational journal of molecular sciences2022

Gene- and Gender-Related Decrease in Serum BDNF Levels in Alzheimer's Disease.

Daniela Piancatelli, Anna Aureli, Pierluigi Sebastiani, Alessia Colanardi, Tiziana Del Beato, Lorenza Del Cane, Patrizia Sucapane, Carmine Marini, Silvia Di Loreto

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. BDNF-amyloid-Frontiers in molecular neuroscience · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Blockade of adenosine AAlzheimer's research & therapy · 2023
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Daniela PiancatelliNational Research Council (CNR)-Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.ORCID 0000-0002-8518-1378
Anna AureliNational Research Council (CNR)-Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.ORCID 0000-0003-3533-4265
Pierluigi SebastianiNational Research Council (CNR)-Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.
Alessia ColanardiNational Research Council (CNR)-Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.
Tiziana Del BeatoNational Research Council (CNR)-Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.
Lorenza Del CaneDepartment of Life, Health and Environmental Sciences (MeSVA), University of L'Aquila, 67100 L'Aquila, Italy.
Patrizia SucapaneNeurology Unit, ASL1, San Salvatore Hospital, 67100 L'Aquila, Italy.
Carmine MariniDepartment of Life, Health and Environmental Sciences (MeSVA), University of L'Aquila, 67100 L'Aquila, Italy.
Silvia Di LoretoNational Research Council (CNR)-Institute of Translational Pharmacology (IFT), 67100 L'Aquila, Italy.ORCID 0000-0002-8256-5819
Istituto di Farmacologia Traslazionale · ITUniversity of L'Aquila · ITSan Salvatore Hospital · IT

Funding

MIUR, Progetto Bandiera "Nanomax" CNR ref. DFM.AD005.058
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) has a protective role in Alzheimer's disease (AD). Oxidative stress and inflammatory cytokines are potentially implicated in AD risk. In this study, BDNF was detected in serum of AD and mild cognitive impairment (MCI) patients and investigated in association with gene polymorphisms of BDNF (Val66Met and C270T), of some oxidative stress-related genes (FOXO3A, SIRT3, GLO1, and SOD2), and of interleukin-1 family genes (IL-1α, IL-1β, and IL-38). The APOE status and mini-mental state examination (MMSE) score were also evaluated. Serum BDNF was significantly lower in AD (

Indexed as

Alzheimer DiseaseBrain-Derived Neurotrophic FactorCognitive DysfunctionSex FactorsAllelesFemaleHumansInterleukinsMalePolymorphism, GeneticBDNF protein, humanBrain-Derived Neurotrophic FactorIL-38 protein, humanInterleukinsAlzheimer’s diseasebrain-derived neurotrophic factor (BDNF)cytokinesgenderoxidative stress

Identifiers

PMID36498925
PMCPMC9740390
OpenAlexW4309946807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.